Neonatal abstinence syndrome is a group of problems that occur in a newborn who was exposed to addictive substance while in the mother’s womb.


The National Institutes of Health’s National Institute on Drug Abuse (NIDA) has featured Dr. Hendrée Jones, executive director of UNC Horizons Program and a professor of obstetrics and gynecology at the UNC School of Medicine, in a series videos discussing neonatal abstinence syndrome and how to best treat it.

In 2010, Dr. Jones’ groundbreaking research that showed that babies born to women with opioid use disorder fare better when their mothers are treated with medication used to treat patients with that disorder – buprenorphine or methadone – than babies whose mothers are not treated at all.

In 2015, Dr. Jones was selected as a NIDA International Program Awards of Excellence winner for her international efforts to advance drug abuse research and training.